BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, July 30, 2026
Breaking News: Best of BioWorld Science: Q2
Breaking News: Science fiction realized: BCI tech is here
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Repros receives positive feedback on Androxal from FDA
Aug. 10, 2010
Daiichi Sankyo presents new agents for treatment of osteoporosis
Aug. 10, 2010
FDA to complete review of lorcaserin NDA in October
Aug. 9, 2010
Elder Pharmaceuticals discovers new glucose-lowering agents
Aug. 9, 2010
BPR-0912 exhibits antiobesity effects in vivo
Aug. 9, 2010
Takeda presents new glucokinase activators
Aug. 6, 2010
Preclinical study implicates GPR55 in regulation of osteoclast number and function
Aug. 6, 2010
CANOE trial data support use of Avandamet to prevent type 2 diabetes
Aug. 6, 2010
New FPS inhibitors discovered at Novartis
Aug. 6, 2010
Santhera discloses new MC4 receptor antagonists
Aug. 6, 2010
Previous
1
2
…
680
681
682
683
684
685
686
687
688
…
1801
1802
Next